Trending...
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
Mental health industry watchdog discloses that 3.3 million U.S. children are given psychiatric drugs despite WHO disapproving of these for children younger than 12
LOS ANGELES - ncarol.com -- In a recent Lancet Psychiatry article, experts have supported the World Health Organization's decision to withhold essential medicine status from methylphenidate, a drug used for Attention Deficit Hyperactivity Disorder (ADHD). The latest WHO Model List of Essential Medicines (EML) has gone even further by removing the antipsychotics chlorpromazine and haloperidol, and the antidepressant fluoxetine for children. Indeed, "The current EML contains no medications of any kind to treat mental disorders in children younger than 12 years, which aligns with current evidence," Lancet reported.[1] Despite this, the Citizens Commission on Human Rights International says that over 3 million U.S. children aged 12 and younger are prescribed psychiatric drugs, as per statistics from the IQVia Total Patient Tracker database.[2]
IQVia statistics reveal that of the 3.3 million, 1,809,101 are prescribed stimulants for ADHD; 336,125 are prescribed antipsychotics, and 581,979 are prescribed antidepressants—the latter, however, are not indicated in anyone younger than 24 because of the risk of suicide. CCHR said the psychotropic drugging of America's children is shameful and putting them at risk.
Ole Jakob Storebø from the Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Denmark, and colleagues wrote, "WHO indicates that precautions are warranted regarding any pharmacological treatment of mental disorders for children younger than 12 years. From an evidence-based perspective, we believe the precautions to be an ethical and sound stance."
Before their passing, the doctors responsible for putting ADHD on the map were aghast at what they helped create. Child psychiatrist Leon Eisenberg, the "scientific father of ADHD", along with child psychologist Keith Conners, Ph.D., conducted clinical trials on methylphenidate in the 1960s. In 2009, he remorsefully called ADHD a "prime example of a fictitious disease."[3] In 2013, Conners said he was appalled at how many children were saddled with the diagnosis, calling it "a national disaster of dangerous proportion."[4]
In 2015, CCHR notified the UN Committee on the Rights of the Child (UNCRC) of the aggressive worldwide diagnosing of ADHD and stimulants prescribed to children, resulting in UNCRC hearings being held. The agency found that "educational resources and funding systems for practitioners are geared toward a 'quick fix'" and recommended the establishment of a system for "monitoring of the excessive use of psychostimulants to children." It called for governments to "take the necessary measures to prevent any pressure on children and parents to accept treatment with psychostimulant drugs."[5]
More on ncarol.com
In 2018, and again in 2020, the WHO Expert Committee on the selection and use of essential medicines declined to grant the stimulant drug methylphenidate the status of an essential medicine.[6]
The U.S. Drug Enforcement Administration classifies methylphenidate as a high-abuse Schedule II drug, in the same category as morphine, opium and cocaine. A study in the Journal of Neuroscience said it is more potent than cocaine.[7]
Other stimulant side effects include nervousness, insomnia, blood pressure and pulse changes, weight loss, heart attacks, strokes and sudden death, and new or worsening aggression and hostility.[8] Methylphenidate's manufacturer warns it is a drug of dependency.[9] Last year, the Food and Drug Administration acknowledged ADHD drugs can cause addiction, even when used as prescribed, and required this information be added to its black box warning on all stimulant drugs.[10]
Students also abuse these drugs. Researchers at the University of California, San Diego School of Medicine found brain scans of college students who abused stimulants showed impaired neuronal activity. "If you show me 100 college students and tell me which ones have taken stimulants a dozen times, I can tell you those students' brains are different," Dr. Martin Paulus, professor of psychiatry, said.[11]
In a groundbreaking September 2005 study, the Evidence-based Practice Center of Oregon Health & Science University analyzed 2,287 studies, encompassing virtually all research on ADHD drugs. Surprisingly, none of the trials demonstrated the effectiveness of these drugs, and there was insufficient evidence supporting their positive impact on "academic performance, risky behaviors, social achievements, etc."[12]
The anomaly is the American Psychiatric Association admits, "There are no laboratory tests, neurological assessments, or attentional assessments that have been established as diagnostic in the clinical assessment" of ADHD.[13] The diagnosis is largely based on subjective behavioral symptoms, including not sitting still, losing pencils and not finishing chores.
Kelly O'Meara, former Congressional staff and author of Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill, summed it up: "In essence, what is happening is that millions of American children are being put on mind-altering drugs—the equivalent of cocaine—every day and often for years on end, to treat a mental illness that no one can say with certainty an objective, confirmable abnormality exists. The best and brightest in mental health admit they are speculating—guessing—effectively using America's children as dice in a psychopharmacological crapshoot."[14]
More on ncarol.com
About CCHR: CCHR was founded in 1969 by the Church of Scientology and the late Dr. Thomas Szasz, Professor of Psychiatry. It has helped achieve over 190 laws to protect the rights of patients within the mental health system.
[1] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[2] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/
[3] www.cchrint.org/2022/02/14/new-diagnostic-manual-with-adhd-listed-could-turn-childhood-into-a-mental-disorder/
[4] www.cchrint.org/2017/08/23/teen-overdose-deaths-from-adhd-anti-anxiety-drugs-on-the-rise/, citing: www.scientificamerican.com/article/big-pharma-s-manufactured-epidemic-the-misdiagnosis-of-adhd; rss.onlinelibrary.wiley.com/doi/full/10.1111/j.1740-9713.2016.00979.x
[5] www.cchr.org/newsletter/2015-summer-child-drugging-reports-worldwide-abuse.html; www2.ohchr.org/english/bodies/crc/docs/co/crc-c-can-co-3-4_en.pdf; docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=6QkG1d%2FPPRiCAqhKb7yhskw6ZHlSjLETdRql6Pfo3d19G0fwi7ZPZdEOVKAQgeqWKogX2iXEvcG5O%2BzGKtEo1nvnVtG%2FXYEnmWa47plmDxnXlhPMHh5Fz%2FKc%2FL6gvzos
[6] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[7] www.deadiversion.usdoj.gov/drug_chem_info/methylphenidate.pdf; Brian Vastag, "Pay Attention: Ritalin Acts Much Like Cocaine," JAMA, 22/29 Aug. 2001, Vol. 286, No. 5, p. 906
[8] Physicians' Desk Reference, (Medical Economics Company, New Jersey, 1998), pp. 1896-1897; DSM-III, p. 150; PDR.Net, www.pdr.net/drug-summary/?drugLabelId=1003; Ricardo Alonso-Zaldivar, "Warning Urged for ADHD Drugs," Los Angeles Times, Feb. 10, 2005; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[9] www.novartis.com/us-en/sites/novartis_us/files/ritalin_la.pdf
[10] www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/; "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions," FDA 11 May 2023; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[11] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[12] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[13] Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, (American Psychiatric Association, Washington D.C. 2000), pp. 88-89
[14] Kelly Patricia O'Meara, Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill, (AuthorHouse, 2006), p. 75
IQVia statistics reveal that of the 3.3 million, 1,809,101 are prescribed stimulants for ADHD; 336,125 are prescribed antipsychotics, and 581,979 are prescribed antidepressants—the latter, however, are not indicated in anyone younger than 24 because of the risk of suicide. CCHR said the psychotropic drugging of America's children is shameful and putting them at risk.
Ole Jakob Storebø from the Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Denmark, and colleagues wrote, "WHO indicates that precautions are warranted regarding any pharmacological treatment of mental disorders for children younger than 12 years. From an evidence-based perspective, we believe the precautions to be an ethical and sound stance."
Before their passing, the doctors responsible for putting ADHD on the map were aghast at what they helped create. Child psychiatrist Leon Eisenberg, the "scientific father of ADHD", along with child psychologist Keith Conners, Ph.D., conducted clinical trials on methylphenidate in the 1960s. In 2009, he remorsefully called ADHD a "prime example of a fictitious disease."[3] In 2013, Conners said he was appalled at how many children were saddled with the diagnosis, calling it "a national disaster of dangerous proportion."[4]
In 2015, CCHR notified the UN Committee on the Rights of the Child (UNCRC) of the aggressive worldwide diagnosing of ADHD and stimulants prescribed to children, resulting in UNCRC hearings being held. The agency found that "educational resources and funding systems for practitioners are geared toward a 'quick fix'" and recommended the establishment of a system for "monitoring of the excessive use of psychostimulants to children." It called for governments to "take the necessary measures to prevent any pressure on children and parents to accept treatment with psychostimulant drugs."[5]
More on ncarol.com
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
- Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
- STEM For Kids® Unveil Turn-Key "Screen-Smart" Solution to Bridge Teacher Preparedness Gaps in Texas
- Award-Winning Couture Master Perfumer JoAnne Bassett Launches All-Natural DIY Perfume Making Kits
In 2018, and again in 2020, the WHO Expert Committee on the selection and use of essential medicines declined to grant the stimulant drug methylphenidate the status of an essential medicine.[6]
The U.S. Drug Enforcement Administration classifies methylphenidate as a high-abuse Schedule II drug, in the same category as morphine, opium and cocaine. A study in the Journal of Neuroscience said it is more potent than cocaine.[7]
Other stimulant side effects include nervousness, insomnia, blood pressure and pulse changes, weight loss, heart attacks, strokes and sudden death, and new or worsening aggression and hostility.[8] Methylphenidate's manufacturer warns it is a drug of dependency.[9] Last year, the Food and Drug Administration acknowledged ADHD drugs can cause addiction, even when used as prescribed, and required this information be added to its black box warning on all stimulant drugs.[10]
Students also abuse these drugs. Researchers at the University of California, San Diego School of Medicine found brain scans of college students who abused stimulants showed impaired neuronal activity. "If you show me 100 college students and tell me which ones have taken stimulants a dozen times, I can tell you those students' brains are different," Dr. Martin Paulus, professor of psychiatry, said.[11]
In a groundbreaking September 2005 study, the Evidence-based Practice Center of Oregon Health & Science University analyzed 2,287 studies, encompassing virtually all research on ADHD drugs. Surprisingly, none of the trials demonstrated the effectiveness of these drugs, and there was insufficient evidence supporting their positive impact on "academic performance, risky behaviors, social achievements, etc."[12]
The anomaly is the American Psychiatric Association admits, "There are no laboratory tests, neurological assessments, or attentional assessments that have been established as diagnostic in the clinical assessment" of ADHD.[13] The diagnosis is largely based on subjective behavioral symptoms, including not sitting still, losing pencils and not finishing chores.
Kelly O'Meara, former Congressional staff and author of Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill, summed it up: "In essence, what is happening is that millions of American children are being put on mind-altering drugs—the equivalent of cocaine—every day and often for years on end, to treat a mental illness that no one can say with certainty an objective, confirmable abnormality exists. The best and brightest in mental health admit they are speculating—guessing—effectively using America's children as dice in a psychopharmacological crapshoot."[14]
More on ncarol.com
- Couture Master Perfumer JoAnne Bassett Offers Rare Opportunity to Acquire 70 Formula Perfume Codex
- Slotozilla Reports Strong Growth in Q2 2026
- Flexible Plan Investments Names Carl Resnick President
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
About CCHR: CCHR was founded in 1969 by the Church of Scientology and the late Dr. Thomas Szasz, Professor of Psychiatry. It has helped achieve over 190 laws to protect the rights of patients within the mental health system.
[1] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[2] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/
[3] www.cchrint.org/2022/02/14/new-diagnostic-manual-with-adhd-listed-could-turn-childhood-into-a-mental-disorder/
[4] www.cchrint.org/2017/08/23/teen-overdose-deaths-from-adhd-anti-anxiety-drugs-on-the-rise/, citing: www.scientificamerican.com/article/big-pharma-s-manufactured-epidemic-the-misdiagnosis-of-adhd; rss.onlinelibrary.wiley.com/doi/full/10.1111/j.1740-9713.2016.00979.x
[5] www.cchr.org/newsletter/2015-summer-child-drugging-reports-worldwide-abuse.html; www2.ohchr.org/english/bodies/crc/docs/co/crc-c-can-co-3-4_en.pdf; docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=6QkG1d%2FPPRiCAqhKb7yhskw6ZHlSjLETdRql6Pfo3d19G0fwi7ZPZdEOVKAQgeqWKogX2iXEvcG5O%2BzGKtEo1nvnVtG%2FXYEnmWa47plmDxnXlhPMHh5Fz%2FKc%2FL6gvzos
[6] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[7] www.deadiversion.usdoj.gov/drug_chem_info/methylphenidate.pdf; Brian Vastag, "Pay Attention: Ritalin Acts Much Like Cocaine," JAMA, 22/29 Aug. 2001, Vol. 286, No. 5, p. 906
[8] Physicians' Desk Reference, (Medical Economics Company, New Jersey, 1998), pp. 1896-1897; DSM-III, p. 150; PDR.Net, www.pdr.net/drug-summary/?drugLabelId=1003; Ricardo Alonso-Zaldivar, "Warning Urged for ADHD Drugs," Los Angeles Times, Feb. 10, 2005; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[9] www.novartis.com/us-en/sites/novartis_us/files/ritalin_la.pdf
[10] www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/; "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions," FDA 11 May 2023; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[11] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[12] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[13] Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, (American Psychiatric Association, Washington D.C. 2000), pp. 88-89
[14] Kelly Patricia O'Meara, Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill, (AuthorHouse, 2006), p. 75
Source: Citizens Commission on Human Rights
Filed Under: Health
0 Comments
Latest on ncarol.com
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
- Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
- DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
- Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
- Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
- Lease A Sales Rep Rebands to Rent A Sales Rep
- The Golden Jazz Fest Shuttle Returns for 2026
- KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night
- Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
- Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
- 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
- Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
- Hollywood In Pixels Announces Honorees for The 9th Silver PIXel Awards
- New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
- GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
- LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards
- Bronze Stevie Award Recognizes Satyadhar Joshi for AI Research and Public Policy Engagement
- Plumber Pros of Clayton NC Opens as Johnston County's #1-Rated Plumbing Choice
